Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single‐Molecule Spectroscopy

The conformation of the activation loop (T‐loop) of protein kinases underlies enzymatic activity and influences the binding of small‐molecule inhibitors. By using single‐molecule fluorescence spectroscopy, we have determined that phosphorylated Aurora A kinase is in dynamic equilibrium between a DFG...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition 2017-09, Vol.56 (38), p.11409-11414
Main Authors: Gilburt, James A. H., Sarkar, Hajrah, Sheldrake, Peter, Blagg, Julian, Ying, Liming, Dodson, Charlotte A.
Format: Article
Language:English
Subjects:
activation loop
Aurora Kinase A - antagonists & inhibitors
Aurora Kinase A - metabolism
Aurora A
Communication
Communications
drug design
Fluorescence
Humans
kinases
Ligands
Models, Molecular
Protein Kinase Inhibitors - chemical synthesis
Protein Kinase Inhibitors - chemistry
Protein Kinase Inhibitors - pharmacology
single-molecule studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The conformation of the activation loop (T‐loop) of protein kinases underlies enzymatic activity and influences the binding of small‐molecule inhibitors. By using single‐molecule fluorescence spectroscopy, we have determined that phosphorylated Aurora A kinase is in dynamic equilibrium between a DFG‐in‐like active T‐loop conformation and a DFG‐out‐like inactive conformation, and have measured the rate constants of interconversion. Addition of the Aurora A activating protein TPX2 shifts the equilibrium towards an active T‐loop conformation whereas addition of the inhibitors MLN8054 and CD532 favors an inactive T‐loop. We show that Aurora A binds TPX2 and MLN8054 simultaneously and provide a new model for kinase conformational behavior. Our approach will enable conformation‐specific effects to be integrated into inhibitor discovery across the kinome, and we outline some immediate consequences for structure‐based drug discovery. Dye quenching and single‐molecule fluorescence spectroscopy were used to monitor the conformation of the activation loop of Aurora A in solution. The position of the equilibrium between active and inactive conformations is changed by kinase ligands. Simple induced‐fit or conformational‐selection models do not explain the data. This has several consequences for drug design.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.201704654